![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2022
Wuerstlein, R.; Ellis, P.; Montemurro, F.; Anton Torres, A.; Delaloge, S.; Zhang, Q.; Wang, X.; Wang, S.; Shao, Z.; Li, H.; Rachman, A.; Vongsaisuwon, M.; Liu, H.; Fear, S.; Pena-Murillo, C. und Barrios, C.
(2022):
Final results of the global and Asia cohorts of KAMILLA, a phase IIIB safety trial of trastuzumab emtansine in patients with HER2-positive advanced breast cancer.
In: Esmo Open, Bd. 7, Nr. 5
[PDF, 484kB]
2020
Montemurro, F.; Delaloge, S.; Barrios, C. H.; Würstlein, R.; Anton, A.; Brain, E.; Hatschek, T.; Kelly, C. M.; Pena-Murillo, C.; Yilmaz, M.; Donica, M. und Ellis, P.
(2020):
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial.
In: Annals of Oncology, Bd. 31, Nr. 10: S. 1350-1358
2017
Montemurro, F.; Ellis, P.; Delaloge, S.; Würstlein, R.; Anton, A.; Button, P.; Lindegger, N. und Barrios, C.
(2017):
Safety and efficacy of trastuzumab emtansine (T-DM1) in 399 patients with central nervous system metastases: Exploratory subgroup analysis from the KAMILLA study.
In: Cancer Research, Bd. 77